Experimentally promising antischistosomal drugs: a review of some drug candidates not reaching the clinical use. (Q34991402)

5 August 2017

1 reference

title

Experimentally promising antischistosomal drugs: a review of some drug candidates not reaching the clinical use. (English)

1 reference

5 August 2017

Rashad A Abdul-Ghani

1

0 references

author name string

Naguiba Loutfy

series ordinal

2

1 reference

PubMed ID

19588166

5 August 2017

Azza Hassan

series ordinal

3

1 reference

5 August 2017

9 July 2009

1 reference

5 August 2017

Parasitology Research

1 reference

5 August 2017

105

1 reference

5 August 2017

4

1 reference

5 August 2017

899-906

1 reference

https://scigraph.springernature.com/pub.10.1007/s00436-009-1546-2

5 August 2017

0 references

cites work

Praziquantel resistance

1 reference

12 December 2020

Identification of an antimalarial synthetic trioxolane drug development candidate

1 reference

12 December 2020

Meclonazepam analogues as potential new antihelmintic agents.

1 reference

12 December 2020

The relationship between tegumental disruption and muscle contraction in Schistosoma mansoni exposed to various compounds

1 reference

12 December 2020

The effects of 3-methylclonazepam on Schistosoma mansoni musculature are not mediated by benzodiazepine receptors

1 reference

12 December 2020

Selective antagonists of benzodiazepines

1 reference

12 December 2020

Will new antischistosomal drugs finally emerge?

1 reference

12 December 2020

Human schistosomiasis

1 reference

12 December 2020

Efficacy of a new Hoffmann-La Roche compound (Ro 15-5458) against Schistosoma mansoni (Gezira strain, Sudan) in vervet monkeys (Cercopithecus aethiops).

1 reference

12 December 2020

Praziquantel and the benzodiazepine Ro 11-3128 do not compete for the same binding sites in schistosomes

1 reference

12 December 2020

Blood 'n' guts: an update on schistosome digestive peptidases

1 reference

12 December 2020

Induction of resistance to Schistosoma mansoni in mice by chemotherapy: migration of schistosomula in primary and challenge infections.

1 reference

12 December 2020

Schistosomiasis mansoni: novel chemotherapy using a cysteine protease inhibitor

1 reference

12 December 2020

Schistosomiasis: forty years' war on the worm

1 reference

12 December 2020

The schistosomicidal compound Ro 15-5458 causes a reduction in the RNA content of Schistosoma mansoni

1 reference

12 December 2020

A benzodiazepine derivative and praziquantel: effects on musculature of Schistosoma mansoni and Schistosoma japonicum

1 reference

12 December 2020

Activity of 9-acridanone-hydrazone drugs detected at the pre-postural phase, in the experimental schistosomiasis mansoni

1 reference

12 December 2020

Efficacy of praziquantel and Ro 15-5458, a 9-acridanone-hydrazone derivative, against Schistosoma haematobium

1 reference

12 December 2020

Schistosomiasis vaccines: the need for more research before clinical trials

1 reference

12 December 2020

Isolation and quantification of fluoroacetate in rat tissues, following dosing of Z-Phe-Ala-CH2-F, a peptidyl fluoromethyl ketone protease inhibitor

1 reference

12 December 2020

Schistosomiasis vaccine:research to development

1 reference

12 December 2020

Dithiol proteins as guardians of the intracellular redox milieu in parasites: old and new drug targets in trypanosomes and malaria-causing plasmodia

1 reference

12 December 2020

Cysteine protease inhibitors as chemotherapy for parasitic infections

1 reference

12 December 2020

Thioredoxin glutathione reductase from Schistosoma mansoni: an essential parasite enzyme and a key drug target

1 reference

12 December 2020

Preliminary results in human schistosomiasis with Ro 11-3128

1 reference

12 December 2020

Reassessment of the cost of chronic helmintic infection: a meta-analysis of disability-related outcomes in endemic schistosomiasis

1 reference

12 December 2020

Biological activities of hydrazone derivatives.

1 reference

12 December 2020

The potential of artemether for the control of schistosomiasis

1 reference

12 December 2020

Schistosoma mansoni: biochemical characteristics of the antischistosomal effects of Ro 15-5458.

1 reference

12 December 2020

Study of the efficacy of the new antischistosomal drug 10-[2-(diethylamino)ethyl]-9-acridanone-(thiazolidin-2-ylidene) hydrazone against an Egyptian strain of S. mansoni in mice.

1 reference

12 December 2020

Identification of oxadiazoles as new drug leads for the control of schistosomiasis

1 reference

12 December 2020

Schistosomiasis: challenges for control, treatment and drug resistance

1 reference

12 December 2020

Characteristics of antischistosomal benzodiazepine binding sites in Schistosoma mansoni

1 reference

12 December 2020

Blueprint for schistosomiasis vaccine development

1 reference

12 December 2020

The synthetic peroxide OZ78 is effective against Echinostoma caproni and Fasciola hepatica

1 reference

12 December 2020

The disulfide redox system of Schistosoma mansoni and the importance of a multifunctional enzyme, thioredoxin glutathione reductase

1 reference

12 December 2020

Antischistosomal activity of acridanone-hydrazones in Cebus monkeys experimentally infected with the SJ strain of Schistosoma mansoni

1 reference

12 December 2020

Quantitative high-throughput screen identifies inhibitors of the Schistosoma mansoni redox cascade

1 reference

12 December 2020

Schistosoma mansoni: serotonin uptake and its drug inhibition

1 reference

12 December 2020

The thioredoxin system—From science to clinic

1 reference

12 December 2020

Resistance induced by drug abbreviated Schistosoma mansoni infections: treatment with the drug Ro11-3128 leads to enhanced antigen presentation

1 reference

12 December 2020

Schistosoma mansoni: genetic complementation analysis shows that two independent hycanthone/oxamniquine-resistant strains are mutated in the same gene.

1 reference

12 December 2020

Cysteine protease inhibitors block schistosome hemoglobin degradation in vitro and decrease worm burden and egg production in vivo

1 reference

12 December 2020

Parasitological evaluation of curative and subcurative doses of 9-acridanone-hydrazone drugs against Schistosoma mansoni in baboons, and observations on changes in serum levels of anti-egg antibodies detected by ELISA.

1 reference

12 December 2020

Schistosomiasis vaccines

1 reference

12 December 2020

Characterization of two classes of benzodiazepine binding sites in Schistosoma mansoni.

1 reference

12 December 2020

Schistosoma mansoni: chemotherapy of infections of different ages

1 reference

12 December 2020

Chemotherapy of schistosomiasis: present and future

1 reference

12 December 2020

In vitro embryotoxicity of the cysteine proteinase inhibitors benzyloxycarbonyl-phenylalanine-alanine-diazomethane (Z-Phe-Ala-CHN2) and benzyloxycarbonyl-phenylalanine-phenylalanine-diazomethane (Z-Phe-Phe-CHN2).

1 reference

12 December 2020

Initial study of methylclonazepam in generalized anxiety disorder. Evidence for greater power in the cross-over design

1 reference

12 December 2020

Effect of a combination of the new antischistosomal drug Ro 15-5458 and praziquantel on different strains of Schistosoma mansoni infected mice.

1 reference

12 December 2020

Schistosomiasis and water resources development: systematic review, meta-analysis, and estimates of people at risk

1 reference

12 December 2020

In vitro and in vivo activities of synthetic trioxolanes against major human schistosome species

1 reference

12 December 2020

Induction of immunity against Schistosoma mansoni by drug (Ro11-3128)-terminated infections: analysis of surface antigen recognition

1 reference

12 December 2020

Prevention and control of schistosomiasis and soil-transmitted helminthiasis

1 reference

12 December 2020

10.1007/S00436-009-1546-2

Identifiers

DOI

1 reference

PubMed ID

19588166

Dimensions Publication ID

5 August 2017

0 references

1 reference

PubMed ID

19588166